Aurobindo Pharma receives final approval for SIMVASTATIN tablets from USFDA

Aurobindo Pharma Ltd has announced that the Company have received 'Final Approval' for 'SIMVASTATIN' tablets 5,10,20,40 & 80 mg from USFDA.

Source : Equity Bulls

Keywords